Explore Global Companies & Account Intelligence

NANO.io is a professional network built for nano and biotech universe. We are starting with an exciting goal in mind empowering professionals to discover a global nanobiotech ecosystem through the industry tailored and carefully designed platform. A platform where beautiful minds can get all the required information, learn new topics, follow ongoing researches, participate in discussions, find jobs, raise funds and much more. We believe that connecting scientists, researchers, companies and investors, we can really boost the emerging nanobiotech revolution.

Comprehensive enterprise dossier available in global intelligence registry.

Nanobiose’s mission is to provide pharma, biotech and cosmetic companies with better tools to improve their in vitro analysis of efficacy / safety of drug candidates. Nanobiose develops SecretCells®, an innovative lab-on-a-chip system to evaluate secreted biomarkers from 2D or 3D perfused cells. SecretCells® combines a microfluidic biochip (where the perfused 3D cell cultures stand) and a removable biosensor for a multiplexed on-line biomarkers analysis. While better mimicking in vivo like conditions, SecretCells® allows more accurate and more predictive results for the evaluation of drug candidates at early stages. SecretCells® is a very flexible solution : - Any 2D/3D cell culture set up - Explants, spheroïds, organoïds, biopsies - Any cell exposure set up, from 1 to 24 hours - Customizable biosensor and reagents kits - Parallelize or serialize assay SecretCells® is easy-to-use : - Adaptable to existing lab equipment (fluorescence microsopes, incubators etc…) - Easy to manipulate with organizer tray - Open and accessible cell culture wells - Possibility to change biosensor without stopping the experiment Potential applications : - Efficacy/cytotoxicity assessment with reduced variability in the measures & better window (vs. 96-w plates) - Cytokines release studies - Study of exposure time vs doses effects - Co-cultures at a distance with intermediate biomarker assessment - Explants / biopsies SecretCells® is a unique patented tool to simultaneously assess the ability of the tested items to elicit / inhibit specific biomarkers responses and their cytotoxic potential. And much more. Contact us to know more : contact@nanobiose.com

Comprehensive enterprise dossier available in global intelligence registry.

NanoBiotech Pharma is a Pioneering & Revolutionary Life Science Company that develops products to address unmet health needs. Our published research shows that our novel approaches are uniquely effective. We are dedicated to our discoveries and development of novel compounds for Cardiology, Urology, Neurology, Pathology and other areas. Our pre-clinical science and clinical research is published and well-established. We now conduct research collaboratively at major institutions. Our flagship nanobiotic product, NanobacTX is designed to structurally address cardiovascular health and functionally improve heart health status. NanobacTX is a Patented non-prescription compound shown in published clinical trials by cardiologists and radiologists to regress calcified plaque volume as measured by decreased Coronary Artery Calcification (CAC) scores, improve lipid profiles and to increase individual exercise tolerance. Objective measurement parameters are markedly improving toward cardiovascular health. NanobacTX and Urobac are globally-patented non-prescription nutraceuticals. They are available for purchase online at http://www.NanoBiotechPharma.com as well as from participating physicians and pharmacies. Get started and improve your cardiovascular health! EMail us at info@NanoBiotechPharma.com

Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanotherapeutics company pioneering new approaches to significantly improve patient outcomes for millions around the world by building new therapies atom by atom. The Nanobiotix philosophy is one rooted in designing pioneer physical-based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. The Nanobiotix global development strategy seeks to address the largest market in oncology—patients who receive radiotherapy as part of their treatment—with NBTXR3 (JNJ-1900). As the first product candidate from the company’s nanoradioenhancer platform, NBTXR3 aims to increase the tumor-killing effect of radiotherapy without increasing damage to surrounding healthy tissues and synergize with other anti-cancer therapies such as immune checkpoint inhibitors. Beyond NBTXR3, the Curadigm Nanoprimer Platform represents the second technology platform from Nanobiotix and the company’s next lever for growth. Curadigm's innovative approach seeks to improve treatment outcomes across several therapeutic classes by optimizing drug bioavailability and efficacy through systemic delivery enhancement. Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP) and on the Nasdaq Global Select Market (Nasdaq: NBTX). The Company’s headquarters are based in Paris, France, with a U.S. affiliate in Cambridge, MA. More: www.nanobiotix.com Read our Social Media Community Guidelines: https://nanobiotix.com/social-community-guidelines/

nanobite Technologies is an IT consulting & professional IT services company with an objective to help UAE companies in the mid-space market as well as global enterprises with multi-location presence to focus on their business and achieve their business goals by harnessing the power of Information Technology and using IT as an enabler for continuous growth and effective information management. We are adept at managing information by harnessing the power of technology and bring our expertise to table for enterprises and generate value for them through our practices, services and consulting.

Nanobiz serves global technology-driven consumer and industrial product clients with strategic and tactical business services focused on generating business growth. The firm, headquartered near New York City, operates through a hybrid employee/independent expert mode and maintains a research and analysis support center in Pune, India. The firm specializes in enabling clients to more rapidly develop new products, increase sales of existing products and move into profitable new markets accelerated by channel partnerships and strategic alliances. Clients come from a broad range of industries including Aerospace, Bio-medical, Chemicals, Cosmetics, Electronics, Energy, Food & Beverage, Manufacturing, Telecommunications and Utilities.

NanoCarrier's core technology, "micellar nanoparticles technology", was proposed and has been researched by Professor Kazunori Kataoka of University of Tokyo, Professor Teruo Okano of Tokyo Women's Medical University. The aforementioned professors demonstrated that when drug-encapsulating micellar nanoparticles were intravenously administered, the particles could function as stable drug carriers in the bloodstream and they accumulated in cancerous tissues. It is hoped that, if efficacy and safety of drugs are further improved by utilizing our micellar nanoparticles technology, we will be able to contribute to the advance in medication of cancer and other intractable diseases. As a pioneer of micellar nanoparticles technology, it is our task to harness the potential of micellar nanoparticles technology to our product development. At present, oncology is the focus area of our development. NanoCarrier technology can deliver small molecules as well as proteins and siRNA. The main products in clinical development are NC-6004 (a Cisplatin based formulation) capable to deliver Cisplatin without the toxicities associated with it. Also NC-4016 is a DachPt micelle formulation capable having as the active ingredient a product similar to Oxaliplatin.

Providing the best quality of life for people is what moves us! We are a DeepTech, focused on the development of new products for monitoring the environment, processes and products. We are currently validating some of our products in a real environment, that is, in a hospital environment. Would you like to known more about our products? Do you want to know a little more about our products? Contact us

Nanocoat International is the exclusive importer of the product portfolio produced and developed by Chemona® Nanocoat Technologies. Nanocoat International delivers high quality coatings based on nano technology for the protection of many different surfaces. Chemona® Nanocoat Technologies has been developing cutting edge Nanocoat Technology coatings for products and materials in different market segments for the past 15 years. The product portfolio is based on innovative Nano Technology specifically designed to be easily applied and extend the life of different surfaces. The environmentally friendly and biodegradable coatings are aimed at reducing costs and maintenance efforts. After the application of the coatings the treated materials and surfaces can be cleaned in a more efficient manner.

Nanocomp is a high-tech company with 20 years of experience in the field of diffractive optics. Nanocomp provides versatile solutions for global customers focusing on design, tooling and mass production of thin foil optics. Main application segments are handheld devices, solid state lighting and diffractive pattern generators.